Disclosures for "From Unknown to Pathogenic: A Case of Cerebellar Ataxia due to RAB3A Variant"
-
Ms. Dyer has nothing to disclose.
-
Dr. Shah-Zamora has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Winthrop Industrie. The institution of Dr. Shah-Zamora has received research support from CereGate Inc. The institution of Dr. Shah-Zamora has received research support from Amneal. The institution of Dr. Shah-Zamora has received research support from AbbVie .
-
Dr. Harmon has nothing to disclose.
-
Mr. Hite has nothing to disclose.